The Federal Drug Administration (FDA) requires a black box warning for gadolinium-related products. This black box warning on the packaging alerts patients to the dangers related to the product. 

It also is meant to prevent any improper or misleading marketing on the box. This packaging will ensure that both patients and administrators correctly use the drug and the recommended dosage for MRI scans. 

If you or anyone you know has suffered negative side effects from using gadolinium, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187.